Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
VUF 11207 is an agonist of chemokine (C-X-C motif) receptor 7 (CXCR7; EC50 = 1.6 nM in a β-arrestin recruitment assay).1 It also reduces CXCR7 cell surface expression in HEK293 cells expressing the human receptor (EC50 = 14.1 nM). VUF 11207 (5 nM) induces the migration and proliferation of primary human pericytes isolated from patients with pulmonary arterial hypertension.2 In vivo, VUF 11207 (5 mg/kg) increases thoracic adventitia thickness and aorta collagen deposition in a mouse model of hypertension induced by angiotensin II.3
WARNING This product is not for human or veterinary use.
1. Synthesis, modeling and functional activity of substituted styrene-
2. Lineage tracing reveals the dynamic contribution of pericytes to the blood vessel remodeling in pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 40(3), 766-782 (2020).
3. Stromal cell-